Home › Funds › Cohen Klingenstein LLC › JNJ

Cohen Klingenstein LLC position in JNJ

JOHNSON & JOHNSON · Health Care

Cohen Klingenstein LLC reported holding 124,109 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$32.9M, representing 0.94% of its reported portfolio and ranking #19 among its reported holdings. Cohen Klingenstein LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)124.11K sh
Reported value held$32.86M
Portfolio Weight0.94%
First reportedQ3 2023
Last changeReduce
Updated2026-10-16

Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR

How Cohen Klingenstein LLC's JNJ position evolved

Cohen Klingenstein LLC first disclosed a stake in JNJ in Q3 2023 at 148,933 shares (US$23.2M). The position peaked in Q3 2026 at 124,109 shares, worth US$32.9M. Across 13 filings, Cohen Klingenstein LLC increased the stake 0 time(s), trimmed it 5 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 124,109 shares valued at US$32.9M — a reduction of -3,885 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 148.93K $23.20M New
Q4 2023 148.93K $23.34M Hold
Q1 2024 145.34K $22.99M Reduce
Q2 2024 145.32K $21.24M Hold
Q3 2024 144.12K $23.36M Reduce
Q4 2024 132.40K $19.15M Reduce
Q1 2025 132.37K $21.95M Hold
Q2 2025 128.76K $19.67M Reduce
Q3 2025 128.35K $23.80M Hold
Q4 2025 127.99K $26.49M Hold
Q1 2026 127.99K $31.29M Hold
Q2 2026 127.99K $32.51M Hold
Q3 2026 124.11K $32.86M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Cohen Klingenstein LLC held JNJ?

Cohen Klingenstein LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Cohen Klingenstein LLC's current position in JNJ?

As of Q3 2026, Cohen Klingenstein LLC holds 124.11K shares of JNJ (JOHNSON & JOHNSON), valued at $32.86M, representing 0.94% of its reported portfolio and ranking #19.

Has Cohen Klingenstein LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Cohen Klingenstein LLC reduced its position in JNJ. The position peaked in Q3 2026 at 124.11K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.